INC Research

INC Research promotes Tierney to executive vice president, Asia/Pacific

Friday, March 1, 2013 02:47 PM

Therapeutically focused CRO INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific, responsible for driving the strategic development and overall growth of Asia/Pacific clinical research operations. Tierney, who was INC Research’s regional general manager for Australia and Southeast Asia, co-founded Trident Clinical Research, an Australia-based CRO acquired by INC Research in 2011 after 14 years of operation.

More... »


Neurovance receives patent for EB-1020, initiates ADHD trial

Friday, February 22, 2013 01:59 PM

The United States Patent and Trademark Office (USPTO) has issued Neurovance, a Cambridge, Mass.-based company spun out of Euthymics Bioscience, a notice of allowance for a composition of matter patent for EB-1020, providing proprietary protection for EB-1020 through July 2026.

More... »


INC Research select goBalto to enhance clinical study startup solution

Monday, January 14, 2013 12:31 PM

INC Research, a therapeutically-focused CRO, has selected a global site activation solution from goBalto, a developer of new-generation web clinical research solutions. goBalto Tracker 2.0 is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials.

More... »

INC Research strengthens leadership for strategic advisory services unit

Monday, December 10, 2012 01:44 PM

INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

More... »

INC Research launches strategic advisory services unit

Wednesday, December 5, 2012 12:02 PM

INC Research, a therapeutically focused CRO, has launched INC Research Strategic Advisory Services, a new global business unit dedicated to providing biopharmaceutical customers with world-class consulting capabilities in the areas of drug development and commercialization, regulatory consulting and submissions and quality assurance.

More... »

INC Research expands in South Korea

Monday, September 17, 2012 09:27 AM

INC Research, a therapeutically focused CRO based in Raleigh, N.C., has opened a facility in Seoul, South Korea to manage the growing demand for world-class clinical development programs.

More... »

INC Research wins IACET accreditation for corporate training

Tuesday, August 28, 2012 12:26 PM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

More... »

INC Research promotes Macdonald to CEO, Ogle to continue as chairman

Friday, August 17, 2012 07:42 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO has, as part of a planned succession, promoted Chief Operating Officer Jamie Macdonald to president and Chief Executive Officer. Chairman and CEO James T. Ogle will continue to serve as chairman.

More... »

INC Research selects TransPerfect’s Trial Interactive as eTMF solution

Thursday, May 17, 2012 09:18 AM

INC Research, a therapeutically focused CRO, has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution, according to TransPerfect, a provider of e-clinical technologies and creator of Trial Interactive. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.

More... »

INC Research expands partnership with Medidata Solutions

Friday, May 11, 2012 11:32 AM

INC Research, a therapy-focused CRO, has broadened its services around Medidata Solutions' clinical cloud platform by attaining three new accreditations.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs